GPCR/G protein


All GPCRs share a common seven trans-membrane structure. GPCRs are associated with heterotrimeric G-proteins which are GTP-binding proteins made of alpha, beta, and gamma subunits. When a ligand binds to GPCR, it activates the attached G-protein, the GDP is replaced with GTP. The activated G-protein then dissociates into an alpha and a beta-gamma complex which activates downstream signaling pathways. These intracellular signaling pathways include cAMP/PKA, calcium/NFAT, phospholipase C, protein tyrosine kinases, MAP kinases, PI-3-kinase, nitric oxide/cGMP, Rho, and JAK/STAT.
GPCRs are one of the most important therapeutic targets for various diseases, over 30% of all modern medicinal drugs target this family. Aberrant GPCR functions are involved in pathological conditions such as neurological, immunological and hormonal disorders. A large number of GPCRs have been identified, but whose ligands are not known, are classified as orphan receptors.
-
B5196 BIM 23056Summary: Somatostatin receptor ligand -
B5217 Sarafotoxin S6aSummary: Endothelin receptor agonist -
B5225 Neuromedin B (porcine)Summary: Mammalian bombesin-like peptide and endogenous ligand for the neuromedin B receptor -
B5228 [D-Phe12]-BombesinSummary: Bombesin receptor antagonist -
B5229 Kinetensin (human)Summary: Endogenous neurotensin-like peptide -
B5230 LitorinSummary: Amphibian bombesin-like peptide -
B5231 Neuromedin U (rat)Summary: Endogenous peptide regulating blood pressure -
B5232 Secretin (rat)Summary: Gastrointestinal peptide that stimulates pancreatic and biliary secretion -
B5234 [D-Lys3]-GHRP-61 CitationTarget: ghrelin receptorSummary: ghrelin receptor antagonist -
B5238 Neuropeptide AF (human)Summary: Endogenous antiopioid peptide implicated in pain modulation and endocrine functions

